Flutemetamol Completed Phase 3 Trials for Healthy Subjects (HS) Diagnostic

Indications	Status	Purpose	Phase
DBCOND0132512 (Healthy Subjects (HS))	Completed	Diagnostic	3

clinicaltrials.gov Identifier	Title	Drugs
NCT01265394	Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects	Flutemetamol (DB15058) Flutemetamol (18F) (DB09151)